Menu Search
Equities

Leveljump Healthcare Corp

JUMP:CVE

Leveljump Healthcare Corp

Actions
Health CareHealth Care Providers
  • Price (CAD)0.05
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change-37.50%
  • Beta2.0369
Data delayed at least 15 minutes, as of May 09 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CADIncome statement in CADView more

Year on year Leveljump Healthcare Corp had net income fall from a gain of 185.01k to a loss of 2.21m despite a 36.35% increase in revenues from 9.23m to 12.58m.
Gross margin13.43%
Net profit margin-14.06%
Operating margin-2.25%
Return on assets-12.33%
Return on equity-36.55%
Return on investment-16.28%
More ▼

Cash flow in CADView more

In 2023, cash reserves at Leveljump Healthcare Corp fell by 12.36k. Cash Flow from Financing totalled 4.89m or 38.85% of revenues. In addition the company generated 662.32k in cash from operations while cash used for investing totalled 5.56m.
Cash flow per share-0.0113
Price/Cash flow per share--
Book value per share0.0479
Tangible book value per share-0.0521
More ▼

Balance sheet in CADView more

Leveljump Healthcare Corp has a Debt to Total Capital ratio of 70.34%, a higher figure than the previous year's 59.59%.
Current ratio0.654
Quick ratio--
Total debt/total equity2.37
Total debt/total capital0.7034
More ▼

Growth rates in CAD

Year on year, growth in earnings per share excluding extraordinary items dropped -1,131.76%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		-744.80
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.